| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$202,708,978 |
|
|
|
Indirect Value
|
$172,941,055 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$375,650,033 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 18 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-11-14 |
4 |
A |
$14.24 |
$284,800 |
I/I |
20,000 |
1,650,423 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-01 |
4 |
B |
$1.96 |
$286,260 |
I/I |
146,230 |
598,254 |
1.5 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-04-06 |
4 |
S |
$3.40 |
$288,575 |
D/D |
(85,000) |
3,633,779 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-01-08 |
4 |
A |
$14.57 |
$291,400 |
I/I |
20,000 |
1,964,423 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-06-03 |
4 |
B |
$2.55 |
$293,482 |
D/D |
115,290 |
4,326,578 |
2.45 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2011-08-05 |
4 |
B |
$14.07 |
$293,639 |
D/D |
20,865 |
3,168,153 |
2.39 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-18 |
4 |
A |
$11.86 |
$296,500 |
I/I |
25,000 |
1,864,423 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-05-25 |
4 |
B |
$1.94 |
$299,807 |
D/D |
126,215 |
3,774,509 |
2.45 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
10% Owner |
– – • |
2015-07-28 |
4 |
B |
$15.00 |
$300,000 |
I/I |
20,000 |
1,279,903 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-04-09 |
4 |
S |
$1.20 |
$300,425 |
I/I |
(250,000) |
10,083,281 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-04-08 |
4 |
S |
$1.21 |
$300,800 |
I/I |
(248,636) |
10,333,281 |
0 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-17 |
4 |
A |
$12.37 |
$309,250 |
I/I |
25,000 |
1,839,423 |
0 |
- |
|
| BDSX |
Biodesix Inc |
|
• • • |
2022-12-14 |
4 |
B |
$1.65 |
$312,945 |
I/I |
189,675 |
20,309,189 |
0.01 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-01-29 |
4 |
B |
$10.18 |
$314,236 |
I/I |
30,868 |
1,107,891 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-09-28 |
4 |
B |
$5.31 |
$318,483 |
I/I |
59,978 |
17,062,632 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-11-20 |
4 |
A |
$12.95 |
$323,750 |
I/I |
25,000 |
1,675,423 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
10% Owner |
– – • |
2020-02-11 |
4 |
S |
$7.69 |
$328,225 |
I/I |
(42,697) |
428,396 |
0 |
% |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2006-12-13 |
4 |
S |
$13.61 |
$334,430 |
D/D |
(24,499) |
2,803,178 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-06-04 |
4 |
B |
$2.68 |
$337,992 |
D/D |
126,286 |
4,452,864 |
2.45 |
- |
|
| SRCL |
Stericycle Inc |
Chairman |
• • – |
2003-07-14 |
4 |
D |
$46.00 |
$350,014 |
D/D |
(7,609) |
1,375,457 |
|
- |
|
| SRCL |
Stericycle Inc |
Chairman |
• • – |
2003-07-14 |
4 |
OE |
$7.25 |
$350,021 |
D/D |
44,436 |
1,378,718 |
|
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-03-22 |
4 |
B |
$2.37 |
$350,155 |
I/I |
147,645 |
259,052 |
1.5 |
- |
|
| VMSI |
Ventana Medical Systems I... |
Director |
– • – |
2004-12-09 |
4 |
D |
$59.80 |
$358,142 |
D/D |
(5,989) |
1,115,375 |
|
- |
|
| VMSI |
Ventana Medical Systems I... |
Director |
– • – |
2004-12-09 |
4 |
OE |
$10.13 |
$358,213 |
D/D |
29,700 |
1,121,364 |
|
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-05-21 |
4 |
A |
$19.02 |
$367,086 |
I/I |
19,300 |
2,043,723 |
0 |
- |
|
634 Records found
|
|
Page 18 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
